These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 430374)

  • 1. SC 25152: a potent mineralocorticoid antagonist with decreased antiandrogenic activity relative to spironolactone.
    Cutler GB; Sauer MA; Loriaux DL
    J Pharmacol Exp Ther; 1979 Apr; 209(1):144-6. PubMed ID: 430374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three new epoxy-spirolactone derivatives: characterization in vivo and in vitro.
    de Gasparo M; Joss U; Ramjoué HP; Whitebread SE; Haenni H; Schenkel L; Kraehenbuehl C; Biollaz M; Grob J; Schmidlin J
    J Pharmacol Exp Ther; 1987 Feb; 240(2):650-6. PubMed ID: 2949071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SC 25152: A potent mineralocorticoid antagonist with reduced affinity for the 5 alpha-dihydrotestosterone receptor of human and rat prostate.
    Cutler GB; Pita JC; Rifka SM; Menard RH; Sauer MA; Loriaux DL
    J Clin Endocrinol Metab; 1978 Jul; 47(1):171-5. PubMed ID: 263288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental studies on the endocrine side effects of new aldosterone antagonists.
    Nishino Y; Schröder H; el Etreby MF
    Arzneimittelforschung; 1988 Dec; 38(12):1800-5. PubMed ID: 3245852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progestogens with antimineralocorticoid activity.
    Losert W; Casals-Stenzel J; Buse M
    Arzneimittelforschung; 1985; 35(2):459-71. PubMed ID: 4039568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The renal action of spirorenone and other 6 beta,7 beta; 15 beta,16 beta-dimethylene-17-spirolactones, a new type of steroidal aldosterone antagonists.
    Casals-Stenzel J; Buse M; Wambach G; Losert W
    Arzneimittelforschung; 1984; 34(3):241-6. PubMed ID: 6329237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of in vitro and in vivo EDSTAC test battery results for detecting antiandrogenic activity.
    Charles GD; Kan HL; Schisler MR; Bhaskar Gollapudi B; Sue Marty M
    Toxicol Appl Pharmacol; 2005 Jan; 202(1):108-20. PubMed ID: 15589981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mespirenone and other 15,16-methylene-17-spirolactones, a new type of steroidal aldosterone antagonists.
    Losert W; Bittler D; Buse M; Casals-Stenzel J; Haberey M; Laurent H; Nickisch K; Schillinger E; Wiechert R
    Arzneimittelforschung; 1986 Nov; 36(11):1583-600. PubMed ID: 3028435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiandrogenic effects of topically applied spironolactone on the hamster flank organ.
    Weissmann A; Bowden J; Frank BL; Horwitz SN; Frost P
    Arch Dermatol; 1985 Jan; 121(1):57-62. PubMed ID: 3155605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cimetidine is an antiandrogen in the rat.
    Winters SJ; Banks JL; Loriaux DL
    Gastroenterology; 1979 Mar; 76(3):504-8. PubMed ID: 428705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Direct action of mineralocorticoid antagonists on biosynthesis of aldosterone: comparative activities of several new compounds].
    Netchitailo P; Perroteau I; Delarue C; Leboulenger F; Capron MH; Vaudry H
    Can J Physiol Pharmacol; 1983 Jan; 61(1):23-8. PubMed ID: 6301660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 45-year story of the development of an anti-aldosterone more specific than spironolactone.
    Ménard J
    Mol Cell Endocrinol; 2004 Mar; 217(1-2):45-52. PubMed ID: 15134800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiandrogenic effect of spironolactone in rats.
    Basinger GT; Gittes RF
    J Urol; 1974 Jan; 111(1):77-80. PubMed ID: 4813557
    [No Abstract]   [Full Text] [Related]  

  • 14. [Doses levorin display an antiandrogenic action?].
    Kharitonenko TS; Lishnevskaia EB; Shneĭ IV; Sizova IA; Mikhaĭlets GA
    Antibiotiki; 1979 Oct; 24(10):772-6. PubMed ID: 556230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiandrogenic and antirenotropic effect of spironolactone.
    Broulik PD; Stárka L
    Endokrinologie; 1976 Oct; 68(1):35-9. PubMed ID: 1001267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate effect in dogs with the aldosterone receptor blocker eplerenone.
    Levin S; McMahon E; John-Baptiste A; Bell RR
    Toxicol Pathol; 2013 Feb; 41(2):271-9. PubMed ID: 23242577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiandrogenic activities of Glycyrrhiza glabra in male rats.
    Zamansoltani F; Nassiri-Asl M; Sarookhani MR; Jahani-Hashemi H; Zangivand AA
    Int J Androl; 2009 Aug; 32(4):417-22. PubMed ID: 19515171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Androgen receptor binding and antiandrogenic activity of some 4,5-secoandrostanes and ring B cyclopropanoandrostanes.
    Stárka L; Hampl R; Kasal A; Kohout L
    J Steroid Biochem; 1982 Sep; 17(3):331-4. PubMed ID: 6215537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effects of the novel anti-aldosterone compound mespirenone on adrenocortical steroidogenesis in vitro.
    Weindel K; Lewicka S; Vecsei P
    Arzneimittelforschung; 1991 Sep; 41(9):946-9. PubMed ID: 1796922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. (+)-(2R,5S)-4-[4-cyano-3-(trifluoromethyl)phenyl]-2,5-dimethyl-N-[6-(trifluoromethyl)pyridin-3- yl]piperazine-1-carboxamide (YM580) as an orally potent and peripherally selective nonsteroidal androgen receptor antagonist.
    Kinoyama I; Taniguchi N; Toyoshima A; Nozawa E; Kamikubo T; Imamura M; Matsuhisa A; Samizu K; Kawanimani E; Niimi T; Hamada N; Koutoku H; Furutani T; Kudoh M; Okada M; Ohta M; Tsukamoto S
    J Med Chem; 2006 Jan; 49(2):716-26. PubMed ID: 16420057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.